Focused-ultrasound developer InSightec said that its ExAblate MR-guided focused ultrasound system has received clearance from Japan's Ministry of Health, Labor, and Welfare for the treatment of women with uterine fibroids.
GE Healthcare of Chalfont St. Giles, U.K., holds the approval and will distribute ExAblate in Japan, according to InSightec of Tirat Carmel, Israel.
Related Reading
Study: InSightec's ExAblate helps with pain, July 14, 2009
InSightec notches $15 million investment, March 19, 2009
InSightec raises $30 million, November 30, 2007
InSightec proceeds with phase I trial, September 26, 2007
InSightec nabs CE Mark, June 7, 2007
Copyright © 2010 AuntMinnie.com
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
